Access consulting in the Nordics
— for therapies where experience makes a difference
We're a team of senior Nordic market access experts with a unique combination of health economic, medical, commercial and analytical capabilities.
The Macanda team has long backgrounds from the pharmaceutical industry, market access consulting, academia, and payer / HTA agencies in the Nordic countries. With a combined experience of more than 400 market access projects delivered, the team provides solutions to clients with complex market access demands in the biotech, pharmaceutical, and medtech industries.
Unique insights and experience from supporting innovations such as precision medicine, cell- and gene therapies (C&G), advanced therapeutic medicinal products (ATMP) and orphan drugs
High-quality access strategy development for market access in Sweden, Norway, Denmark and Finland
Expert knowledge in launch optimization, landscaping and opportunity assessment
Analytical capabilities incl. health economic modelling, biostatistics and registry-based evidence generation
Experience across the full life-cycle of medical innovations and multiple therapeutical areas
Senior consultants who can challenge and optimise your evidence generation and access plans
Early market access
Evidence generation plans
Landscaping & opportunity assessment
Launch strategy & readiness
Access strategy development
Reimbursement submission planning & development
Negotiation & contracting support
Health economic analysis
Real-world evidence generation & analysis
Join our team
Macanda is looking for an Analyst or Senior Analyst in market access and/or HEOR
We are looking for someone who has a proactive, solution-oriented approach, great analytic capability, and strong communication skills to support the provision of high quality, timely development, and on-time input to client projects. Assignments range in complexity from basic analysis and problem solving to assisting in the development of more complex solutions to leading small teams. Principal accountabilities include to carry out works relating to market access and HEOR to a high standard which meets or exceeds client expectations under supervision, independently and/or as part of a project team on defined tasks.
Macanda can offer an inspiring working environment focused on supporting access solutions for clients launching pharmaceuticals with complex access challenges, such as advanced therapies and orphan drugs, in the Nordic region. We are a senior team working closely together with the ambition to become the premier Market Access consultancy for the Nordics.
Your skills and experience:
Master’s degree in Life sciences/ Economics/ Biostatistics/ Mathematics/ Epidemiology/ Business Administration with strong record of academic achievement
Prior experience or proven interest in the healthcare and life science industries.
Excellent presentation, communication and client relationship building skills
Personable, realistic, willing, open, team-worker and flexible
Well organized and able to work on multiple tasks simultaneously
Enthusiastic to learn and motivated to develop
Fluent in English, written and verbally. Knowledge of Finnish is a plus.
Reach out to firstname.lastname@example.org with your application or if you have any questions about the position/working at Macanda!
2 October, 2023
Macanda had a true Nordic kick-off experience in the archipelago, with sailing, sauna, crayfish, ice-cold swims and creative planning and goal-setting workshops! It feels great going into the fall with such a strong team!
Macanda kicks off the fall
18 September, 2023
Welcome August to our team!
August brings two years of hands-on experience in Health Economics from Uppsala University where his achievement includes a master's thesis project, where he was entrusted by the Dental and Pharmaceutical Benefits Agency (TLV) to create a method for measuring public opinion in healthcare prioritization. This innovative method was later successfully put into practice in a national study conducted at Uppsala University, showcasing August's practical skills and contributions. August also earned the prestigious Uppsala Economics Association's scholarship, a testament to his exceptional aptitude for the subject.
We are excited to have August on board and we look forward to his valuable contributions to our client project! Welcome August!
29 August, 2023
We are overjoyed and honoured to welcome Maria Johansson to Macanda! In Sweden, Maria has held a range of senior positions with payers and HTA bodies for more than 20 years. Most recently she was Head of Unit and member of the management team of value-based pricing (VBP) at the Dental and Pharmaceutical Benefits Agency (TLV). Maria also has expertise from roles in the Expert groups and Drug-and-Therapeutic Committees in the Regions of Västerbotten and Jämtland.
We are eager to introduce Maria to our clients as she has joined as a Director and Senior Advisor in HTA and Clinical Value.
24 April, 2023
We’d like to welcome our newest member of the team, Emin Ekström!
Emin holds 10 years of experience in the field of health economics and is well-versed in many disciplines such as health economic modeling, systematic literature reviews and registry studies. In addition to serving as the designated economist on a committee at the Ministry of Health and Social Affairs (Socialdepartmentet), Emin has a history with Swedish HTA organizations, including the Dental and Pharmaceutical Benefits Agency (TLV) and the Swedish Agency for Health Technology Assessment (SBU). Emin has a MSc in Health Economics and Public Health from University of Gothenburg.
10 February, 2023
We are excited to welcome Chantelle Murley to the growing Macanda team! Last year Chantelle defended her thesis in patient outcomes, sickness absence and socioeconomic consequences of multiple sclerosis at Karolinska Institutet and since then she has been working as a post-doctoral researcher. Before her academic career she had a placement in the policy team at Pharmac (New Zealand's HTA agency).
21 December, 2022
We wish our friends, clients and collaborators Happy Holidays and a safe, healthy, and prosperous New Year!
This year Macanda is supporting Doctors without Borders, MSF. Together, we contribute to life-saving health care — no matter who, where and why.
20 December, 2022
Macanda presents orphan drug market access landscape in Sweden
In anticipation of the upcoming change of presidency of the EU Council, Business Sweden organised a seminar in late November on patient access to rare disease treatments at the Swedish Embassy in Prague, Czech Republic, who holds the current presidency.
The purpose of the seminar, attended by health economists, decision makers, clinicians and patient organizations, was to exchange insights and ideas on the topic of Market Access and Health Economics of orphan drugs in Sweden and the Czech Republic.
Macanda’s Jonas Lindblom was invited to the seminar to present the orphan drug market access landscape in Sweden and the unique challenges that orphan drug companies and patients face in the value based Swedish setting.
1 November, 2022
Macanda is strengthening the team with new partners!
Today Macanda is excited to welcome Marcus Hultberg, Jonas Lindblom and Emma Medin as new partners! Together we are establishing a Nordic market access consultancy for clients with therapies where experience makes a difference.
Emma, Jonas and Marcus hold extensive experience from consulting, medical, commercial, payer and academic roles, and from having supported clients in the Nordics with tailored market access solutions over the past decade. They have developed unique expertise in the field of access for advanced therapies (ATMPs) and orphan drugs in rare diseases and oncology.
Welcome to the team!
22 August, 2022
There is nothing better in work life than to reunite with top talents that you have missed for their smartness and drive. Today is one of those better days, when we welcome our old colleague Josefine Röhss to Macanda!
Josefine sits on a rare competence of statistical skills joined with health-economic experience and has a background in both consultancy and pharma. She is quite the modeller and will help us set the stage for becoming the highest-quality Nordic market access consultancy and tackle the multiple challenges we face in taking new innovations to the market. Additional steps on this journey will be shared later in the fall.
25 March, 2022
Macanda is looking forward to seeing you at SHEA Gothenburg 2022!
Macanda will be attending the Swedish national health-economic conference organised by the Swedish Health Economics Association (SHEA) 6-7 April 2022. Hope to see you there!
Read more about the conference at SHEA's website.
17 March, 2022
Macanda is now a friend company of
Save the Children 2022
We are proud to contribute to the improvement of children’s lives around the world. The devastating war in Ukraine shows how important the humanitarian aid organisations are in enabling timely and effective emergency response, and the need for long-term commitment.
21 December, 2021
successfully defended by Emma Söreskog
On December 21st, Macanda's Emma Söreskog successfully defended her Licentiate thesis "Spinal cord stimulation in chronic pain: a study of health outcomes and costs"at Karolinska Institutet.
Read an abstract of the thesis here.